You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 8, August 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Protease Inhibitors in Plasma of Patients With Chronic Urticaria

Hendrik M. G. Doeglas, MD; Eric Bleumink, PhD

Arch Dermatol. 1975;111(8):979-985.


Abstract

The hypothesis that deficiencies of plasma protease inhibitors might play a role in the pathogenesis of chronic urticaria was evaluated. Plasma levels were measured in patients with urticaria and a matched control group for {alpha}1-antitrypsin, {alpha}2-macroglobulin, total trypsin-inhibiting capacity, kallikrein-inhibiting capacity, and the complement factors C1 esterase inhibitor, C3, and C4.

A total of 92 patients with chronic urticaria of more than three months' duration was studied. Patients with acquired cold urticaria had significantly decreased levels of {alpha}1-antitrypsin and total antitrypsin activity. In patients with acquired angioneurotic edema, {alpha}1-antitrypsin levels and antichymotrypsin activities were lowered, with less significant decreases in antitrypsin and antikallikrein activities. Levels of C1 esterase inhibitor, C3, and C4 were normal in all groups. There was no correlation between the increased sensitivity to intracutaneously administered kallikrein injection and deficiencies of protease inhibitors.



Author Affiliations

From the Department of Dermatology, State University, Groningen, the Netherlands.


Footnotes

Accepted for publication Feb 4, 1975.

Read in part before the fourth meeting of the European Society for Dermatological Research, Amsterdam, April 24, 1974.

Reprint requests to Department of Dermatology, Oostersingel 59, Groningen, the Netherlands (Dr. Doeglas).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med. 2003;168:818-900.
FULL TEXT  

Protease-Inhibitor Deficiencies in a Patient With Weber-Christian Panniculitis
Bleumink and Klokke
Arch Dermatol 1984;120:936-940.
ABSTRACT  

The Physical Urticarias: An Update and Review
Jorizzo and Smith
Arch Dermatol 1982;118:194-201.
ABSTRACT  

Localized Heat Urticaria
Wise et al.
Arch Dermatol 1978;114:1079-1080.
ABSTRACT  

Hypocomplementemia in Chronic Idiopathic Urticaria
MATHISON et al.
ANN INTERN MED 1977;86:534-538.
ABSTRACT  

Alpha1-antitrypsin Deficiency
Crovato and Rebora
Arch Dermatol 1977;113:236-236.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.